Heidelberg Innovation manages two funds with a total volume of Euro 113 million. The first fund of Euro 12 million was sold via a secondary after expiration of its contractual runtime.

Heidelberg Innovation BioScience Venture II

In 2001 the second fund, Heidelberg Innovation BioScience Venture II GmbH & Co. KG (BSV II), was closed with a volume of Euro 93 million. This fund invests supraregionally, above all in Germany and neighbouring countries in life science, medtech and biotechnology companies. The main investors are the European Investment Fund as well as insurance companies, banks, fund-in-fund investors and private individuals. Since inception, three companies achieved an IPO and further four were sold via trade sale.

Heidelberg Innovation parallel participation

As a supplement to BSV II, Heidelberg Innovation Parallel Beteiligungs GmbH & Co. KGaA with a volume of Euro 20 million was established in 2001. This fund invests in parallel to BSV II and therefore has the same investment focus.

Heidelberg Innovation BioScience Venture I

The first fund established in 1997, Heidelberg Innovation GmbH & Co. BioScience Venture KG (BSV I), had a volume of Euro 12 million. After most of its portfolio companies had been exited the fund with the remaining companies was sold via a secondary purchase.